ArticleGastroenterology & hepatology2017
Hepatitis C Point-of-Care Screening in Retail Pharmacies in the United States.
Article in Gastroenterology & hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Peer-Delivered Hepatitis C Testing and Health Screening Provided in a Community Pharmacy Setting: Proof of Concept.Pharmacy (Basel, Switzerland) · 2025Article
- Viral hepatitis testing and treatment in community pharmacies: a systematic review and meta-analysis.EClinicalMedicine · 2024Article
- Pharmacy-based screening program to detect hepatitis C in 'baby-boomer' cohorts in western Canada.Canadian liver journal · 2023Article
- Point-of-care testing in private pharmacy and drug retail settings: a narrative review.BMC infectious diseases · 2023Review
- Implementation and Evaluation of a Collaborative, Pharmacy-Based Hepatitis C and HIV Screening Program.Preventing chronic disease · 2022Article
- Attitudes toward pharmacy-based HCV/HIV testing among people who use drugs in rural Kentucky.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2022Article
- [Current status of nucleic acid testing for hepatitis C].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021Article
- Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study.Harm reduction journal · 2021Article
- Pharmacy-Based Infectious Disease Management Programs Incorporating CLIA-Waived Point-of-Care Tests.Journal of clinical microbiology · 2020Review
- High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: missed opportunities for hepatitis C testing.Harm reduction journal · 2020Article
- Hepatitis C models of care: approaches to elimination.Canadian liver journal · 2020Review
- Hepatitis C elimination: challenges with under-diagnosis and under-treatment.F1000Research · 2019Review
- Pharmacists' Opinions on the Implementation of HIV and HepC Point-of-Care-Testing in a U.S. Pharmacy Chain.Innovations in pharmacy · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
28450816PMC5402690What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.